Cargando…
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
BACKGROUND: The long term outcome of advanced sarcoma patients treated with trabectedin outside of clinical trials and the utility of maintenance treatment has not been reported. METHODS: Between 2003 and 2008, patients with advanced sarcoma failing doxorubicin could be treated within a compassionat...
Autores principales: | Blay, Jean-Yves, Italiano, Antoine, Ray-Coquard, Isabelle, Le Cesne, Axel, Duffaud, Florence, Rios, Maria, Collard, Olivier, Bertucci, François, Bompas, Emmanuelle, Isambert, Nicolas, Chaigneau, Loic, Cassier, Philippe, Bui, Binh, Decanter, Gauthier, Derbel, Olfa, Coindre, Jean-Michel, Zintl, Patrick, Badri, Nadia, Penel, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620689/ https://www.ncbi.nlm.nih.gov/pubmed/23388156 http://dx.doi.org/10.1186/1471-2407-13-64 |
Ejemplares similares
-
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma
por: Maillard, Maud, et al.
Publicado: (2020) -
The off-label use of targeted therapies in sarcomas: the OUTC’S program
por: Eberst, Lauriane, et al.
Publicado: (2014) -
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
por: Khalifa, J., et al.
Publicado: (2015) -
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
por: Pautier, P., et al.
Publicado: (2021) -
New developments in treatment of ovarian carcinoma: focus on trabectedin
por: Cassier, Philippe A, et al.
Publicado: (2010)